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Background: Ischemic electrocardiographic (IECG) changes during Regadenoson stress testing are uncommon but its clinical significance 
is unclear. Recent studies with dipyridamole and adenosine stress testing have reported a benign prognosis in the setting of IECG and normal 
myocardial perfusion imaging (NMPI). We studied the diagnostic and prognostic significance of IECG during regadenoson stress testing, when 
integrated with MPI. 
Methods: Baseline demographics, stress ECG and MPI data were retrospectively collected on 4049 patients that underwent Regadenoson MPI 
between January 2009 and November 2012. MPI was classified as normal or abnormal (AMPI) based on SSS=/>0, respectively. Ischemic (IECG) 
was defined by >1 mm of horizontal or downsloping ST depression during stress, in the absence of baseline ST changes, left bundle branch block 
or left ventricular hypertrophy. Angiographic data was obtained by chart review in patients that underwent coronary angiography within 60 days of 
index MPI. Mortality statistics were obtained from the Social Security Death Index. Primary outcomes were angiographic CAD defined as coronary 
stenosis>70% and all-cause mortality. Outcomes were compared between the following groups: AMPI+ NECG (n= 1112), NMPI+NECG (n=2870), 
AMPI +IECG (n=27), NMPI+IECG (n=40). 
results: The incidence of IECG was low (1.7%, 67/4049) and majority (40/67, 60%) had NMPI. IECG was seen more often in women, age>75 
years, with higher peak stress heart rates, lower left ventricular end-diastolic volumes and higher LVEF (p<0.001). Mean follow-up was 30±15 
months. Incidence of angiographic CAD was similar between the NMPI+IECG and NMPI+NECG groups (38%vs 22% p=0.39) but higher rates were 
noted in AMPI+NECG (48.1 p<0.05) and AMPI+IECG groups (83.3%, p<0.001). The distribution of all-cause mortality across the 4 groups was as 
follows: AMPI+NECG 19%, AMPI+IECG-7.5%, NMPI +NECG-11% and NMPI+IECG 7% (p<0.001). 
conclusions: IECG occurs rarely during regadenoson stress testing and in those with NMPI, is associated with a lower incidence of angiographic 
CAD, including multivessel disease and lower all-cause mortality, compared to groups with AMPI.
